Skip to main navigation Skip to search Skip to main content

Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial

  • Laurens Liesenborghs
  • , Isabel Spriet
  • , Dirk Jochmans
  • , Ann Belmans
  • , Iwein Gyselinck
  • , Laure-Anne Teuwen
  • , Sebastiaan ter Horst
  • , Erwin Dreesen
  • , Tatjana Geukens
  • , Matthias M. Engelen
  • , Ewout Landeloos
  • , Vincent Geldhof
  • , Helga Ceunen
  • , Barbara Debaveye
  • , Bert Vandenberk
  • , Lorenz van der Linden
  • , Sofie Jacobs
  • , Lana Langendries
  • , Robbert Boudewijns
  • , Thuc Nguyen Dan Do
    • Winston Chiu, Xinyu Wang, Xin Zhang, Birgit Weynand, Thomas Vanassche, Timothy Devos, Geert Meyfroidt, Wim Janssens, Robin Vos, Pieter Vermeersch, Joost Wauters, Geert Verbeke, Paul De Munter, Suzanne J. F. Kaptein, Joana Rocha-Pereira, Leen Delang, Eric Van Wijngaerden, Johan Neyts, Peter Verhamme

Research output: Contribution to journal › A1: Peer-reviewed journal articles › peer-review

82 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science